SIRT1 and cancer: It has been reported that Sirt1 displays anti-senescence properties in a wide range of mammalian cells, and that Sirt1 inhibition triggers premature senescence-like replication arrest in human cancer cell lines, characterized by senescence-associated beta-galactosidase activity and increased expression of plasminogen activator inhibitor 1.